>
Amyris Inc logo

AMRS - Amyris Inc Share Price

$15.06 -0.6  -4.0%

Last Trade - 16/04/21

Sector
Basic Materials
Size
Large Cap
Market Cap £2.98bn
Enterprise Value £3.16bn
Revenue £125.2m
Position in Universe 1587th / 6850
Bullish
Bearish
Unlock AMRS Revenue
Momentum
Relative Strength (%)
1m -33.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -35.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
34.2 67.2 127.7 63.6 152.6 173.1 337.5 342.7 +38.4%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, AmyrisInc revenues increased 13% to $173.1M. Net loss applicableto common stockholders increased 41% to $382.3M. Revenuesreflect United States segment increase of 18% to $69.2M,Europe segment increase of 9% to $76.9M. Higher net lossreflects Loss from change in fair value of debt increasefrom $19.4M to $89.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for AMRS
Graphical History

Revenue

AMRS Revenue Unlock AMRS Revenue

Net Income

AMRS Net Income Unlock AMRS Revenue

Normalised EPS

AMRS Normalised EPS Unlock AMRS Revenue

PE Ratio Range

AMRS PE Ratio Range Unlock AMRS Revenue

Dividend Yield Range

AMRS Dividend Yield Range Unlock AMRS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
AMRS EPS Forecasts Unlock AMRS Revenue
Profile Summary

Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into volume, high-value ingredients. Its biotechnology platform and industrial fermentation process replace existing complex and expensive manufacturing processes. The Company’s platform is used to design, build, optimize and upscale strains producing eight distinct molecules at commercial volumes, to more than 15 commercial ingredients.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 15, 2010
Public Since September 28, 2010
No. of Shareholders: 84
No. of Employees: 595
Sector Basic Materials
Industry Chemicals
Index Nasdaq Composite ,
Exchange NASDAQ Global Select Market
Shares in Issue 273,266,917
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AMRS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AMRS
Upcoming Events for AMRS
Thursday 22nd April, 2021
Amyris Inc Third Virtual Investor Mini-Series Webinar
Thursday 6th May, 2021 Estimate
Q1 2021 Amyris Inc Earnings Release
Friday 28th May, 2021
Amyris Inc Annual Shareholders Meeting
Friday 28th May, 2021 Estimate
Amyris Inc Annual Shareholders Meeting
Wednesday 4th August, 2021 Estimate
Q2 2021 Amyris Inc Earnings Release
Frequently Asked Questions for Amyris Inc
What is the Amyris Inc share price?

As of 16/04/21, shares in Amyris Inc are trading at $15.06, giving the company a market capitalisation of £2.98bn. This share price information is delayed by 15 minutes.

How has the Amyris Inc share price performed this year?

Shares in Amyris Inc are currently trading at $15.06 and the price has moved by 0.569k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Amyris Inc price has moved by 0.361k% over the past year.

What are the analyst and broker recommendations for Amyris Inc?

Of the analysts with advisory recommendations for Amyris Inc, there are there are currently 2 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Amyris Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Amyris Inc next release its financial results?

Amyris Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Amyris Inc dividend yield?

Amyris Inc does not currently pay a dividend.

Does Amyris Inc pay a dividend?

Amyris Inc does not currently pay a dividend.

When does Amyris Inc next pay dividends?

Amyris Inc does not currently pay a dividend.

How do I buy Amyris Inc shares?

To buy shares in Amyris Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Amyris Inc?

Shares in Amyris Inc are currently trading at $15.06, giving the company a market capitalisation of £2.98bn.

Where are Amyris Inc shares listed? Where are Amyris Inc shares listed?

Here are the trading details for Amyris Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: AMRS
What kind of share is Amyris Inc?

Based on an overall assessment of its quality, value and momentum, Amyris Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Amyris Inc share price forecast 2021?

Shares in Amyris Inc are currently priced at $15.06. At that level they are trading at 76.63% discount to the analyst consensus target price of 0.00.

Analysts covering Amyris Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.118 for the next financial year.

How can I tell whether the Amyris Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Amyris Inc. Over the past six months, the relative strength of its shares against the market has been 0.339k%. At the current price of $15.06, shares in Amyris Inc are trading at 99.88% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Amyris Inc PE Ratio?

We were not able to find PE ratio data for Amyris Inc.

Who are the key directors of Amyris Inc?

Amyris Inc's management team is headed by:

John Melo - CEO
John Doerr - IND
Geoffrey Duyk - CHM
Kathleen Valiasek - OTH
Philip Eykerman - DRC
Eduardo Alvarez - COO
Frank Kung - IND
James McCann - IND
Nicole Kelsey - GCN
Han Kieftenbeld - CFO
Julie Washington - DRC
Sheila Pollak - CMO
Francisco Costa - OTH
Who are the major shareholders of Amyris Inc?

Here are the top five shareholders of Amyris Inc based on the size of their shareholding:

Foris Ventures, L.L.C. Corporation
Percentage owned: 21.4% (58.5m shares)
Farallon Capital Management, L.L.C. Hedge Fund
Percentage owned: 6.4% (17.5m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 6.13% (16.7m shares)
Koninklijke DSM NV Corporation
Percentage owned: 6.11% (16.7m shares)
Vivo Capital, LLC Venture Capital
Percentage owned: 4.82% (13.2m shares)
Similar to AMRS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.